Table 2:
Animal Model/Subtype | Immunogenicity | Reproducible Tumor-Host Interaction | Tumor Take and Growth Rate | Reproducibility of Human HGG Genetics and Biology | Stromal Disruption | High-Throughput Preclinical Trials |
---|---|---|---|---|---|---|
Exogenous models or xenografts | ||||||
Syngeneic | None/low | Yes | ||||
Heterogeneic | High/requires nude mice | Yes | ||||
Orthotopic | Yes | Yes | ||||
Heterotopic | No | Yes | ||||
Cell suspension | High | Yes | ||||
Spheroids | Moderate | Yes | ||||
Tumor explants: | Low | No | ||||
From primary cell lines | High | Depends on the cell line | ||||
From patient tumors | Low | High | ||||
Endogenous models | ||||||
Carcinogenically induced (RT, QT, viral mutagenesis) | No | |||||
GEMMs | No | |||||
Transplantable GEMMs | Yes |
Note:—RT indicates radiation therapy; QT, chemotherapy.